Jan van der Veen

Ask VT AI
View News Summary
  • Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
  • Apple forecasts strong holiday revenue growth driven by exceptional demand for the new iPhone 17 models, despite supply challenges and tariff costs.
  • Delta urges Congress to end the record-breaking government shutdown that is disrupting air traffic and impacting essential workers.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
  • Apple forecasts strong holiday revenue growth driven by exceptional demand for the new iPhone 17 models, despite supply challenges and tariff costs.
  • Delta urges Congress to end the record-breaking government shutdown that is disrupting air traffic and impacting essential workers.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Jan van der Veen